HOPMAN MARK (Chief Commercial Officer) sold 0.3% of their position (353.00 shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $4.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0002048497-26-000002
Officer· Chief Commercial Officer
Since Mar 2026
-353.00
Net shares
Net seller
$4.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
353.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−353.00
Price / share
$11.57
Trade value
$4.08K
% of position
0.3%
3/4/2026
139.49K→139.13K
Total
Net shares
−353.00
Net value
-$4.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | S · Sale | −353.00 | $11.57 | $4.08K | 0.3% | 139.49K | 139.13K |
| Total | −353.00 | -$4.08K | ||||||
Derivative Transactions0
No derivative transactions reported